These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23494466)

  • 1. Generic substitution, financial interests, and imperfect agency.
    Rischatsch M; Trottmann M; Zweifel P
    Int J Health Care Finance Econ; 2013 Jun; 13(2):115-38. PubMed ID: 23494466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greek students' attitudes, perception and knowledge regarding generic medicines in times of economic crisis: a cross-sectional study.
    Domeyer PJ; Katsari V; Sarafis P; Aletras V; Niakas D
    BMC Med Educ; 2018 Nov; 18(1):262. PubMed ID: 30442145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescription of generic drugs to privately insured persons].
    Wild F
    Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
    Scott AB; Culley EJ; O'Donnell J
    J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic notifications about drug substitutes can change physician prescription habits: a cross-sectional observational study.
    Zuker A; Heart T; Parmet Y; Pliskin N; Pliskin JS
    Med Decis Making; 2011; 31(3):395-404. PubMed ID: 21127317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
    Fuksa L; Vocelka M; Vytrisalova M
    Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices.
    Hoffmann F; Glaeske G; Pfannkuche MS
    Dtsch Arztebl Int; 2009 Nov; 106(48):783-8. PubMed ID: 20038980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling strategies for reducing pharmaceutical costs in hospital.
    MacIntyre CR; Sindhusake D; Rubin G
    Int J Qual Health Care; 2001 Feb; 13(1):63-9. PubMed ID: 11330446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications.
    Truter I; Shankar S; Bennie M; Woerkom Mv; Godman B
    J Comp Eff Res; 2015 Mar; 4(2):123-31. PubMed ID: 25825841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.
    Fadare JO; Adeoti AO; Desalu OO; Enwere OO; Makusidi AM; Ogunleye O; Sunmonu TA; Truter I; Akunne OO; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):639-650. PubMed ID: 26567041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of generic drug substitution in Switzerland.
    Decollogny A; Eggli Y; Halfon P; Lufkin TM
    BMC Health Serv Res; 2011 Jan; 11():17. PubMed ID: 21269426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial incentives and physician prescription behavior: Evidence from dispensing regulations.
    Burkhard D; Schmid CPR; Wüthrich K
    Health Econ; 2019 Sep; 28(9):1114-1129. PubMed ID: 31264330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physician survey of the effect of drug sample availability on physicians' behavior.
    Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
    J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician response to financial incentives when choosing drugs to treat breast cancer.
    Epstein AJ; Johnson SJ
    Int J Health Care Finance Econ; 2012 Dec; 12(4):285-302. PubMed ID: 23124970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician profiling in the catheterization laboratory: a worthwhile strategy or a path to futility?
    Vaitkus PT
    J Am Coll Cardiol; 2001 Nov; 38(5):1424-6. PubMed ID: 11691518
    [No Abstract]   [Full Text] [Related]  

  • 20. Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland.
    Rischatsch M
    Eur J Health Econ; 2014 Sep; 15(7):697-708. PubMed ID: 23864366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.